Agomelatine - Isotope Labelled Standards
References
FAQ's
References
- Andrieux, Jean; Houssin, Raymond; Yous, Said; Guardiola, Beatrice; Lesieur, Daniel, Naphthalene Derivatives, Procedure For Their Preparation And Pharmaceutical Compositions Containing Them, EP447285B1, September, 18, 1991
- Markl, Christian; Zlotos, Darius P., A novel synthesis of the antidepressant agomelatine, Synthesis, Issue: 1, Pages: 79-82, 2011
- Patil, Satish R.; Nerurkar, Ketan K.; Kalamkar, Ashok M.; Pukale, Vishwas; Mangaonkar, Kiran V.; Pingale, Satish G., Validated LC-MS/MS method for quantification of agomelatine in human plasma and its application in a pharmacokinetic study, Journal of Mass Spectrometry, Volume: 47, Issue: 1, Pages: 23-28, 2012
Frequently Asked Questions
What is the role of impurity profiling in Agomelatine?
Impurity profiling helps identify and quantify impurities in Agomelatine and develops appropriate control strategies to ensure the drug's quality, safety, and efficacy.
Do impurities in Agomelatine affect the stability of the drug?
Impurities in Agomelatine can affect the stability of the drug by accelerating its degradation or reacting with the drug substance or excipients.
Which solvent helps in the analysis of Agomelatine impurities?
Methanol is a solvent used in analyzing many impurities in Agomelatine.
What are the temperature conditions required to store Agomelatine impurities?
Agomelatine impurities are stored at a controlled room temperature between 2-8 ⁰C or as indicated on the Certificate of Analysis (CoA).
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.